Reaction

Hyperkinesia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,064 reports · 37 co-occurring drugs

As of the last recalculation, Hyperkinesia appears in 2,064 FAERS reports alongside 37 co-occurring drug terms. The strongest observed disproportionality signal is RIVASTIGMINE (PRR 66.9).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Rivastigmine11866.967.4
Rotigotine8561.862.1
Amantadine7953.553.8
Levodopa5244.544.7
Ropinirole6342.742.8
Rasagiline Mesylate4440.740.9
Pramipexole6040.640.8
Carbidopa And Levodopa10523.523.5
Methylphenidate5820.820.8
Valproic Acid5317.417.4
Oxazepam3215.215.2
Methylphenidate Hydrochloride7813.813.8
Ziprasidone2212.712.7
Amphetamine1012.212.3
Aripiprazole Oral4410.911.0
Aripiprazole Orally Disintegrating4410.911.0
Midazolam2610.510.5
Lithium2610.510.5
Lithium Bromatum2610.510.5
Mirtazapine8810.110.1
Haloperidol Lactate249.99.9
Haloperidol239.69.7
Midazolam Hydrochloride259.59.5
Quetiapine1639.29.2
Vigabatrin139.09.1
Clozapine1079.09.0
Candesartan308.68.6
Febuxostat Tablets 40 Mg88.08.0
Febuxostat Tablets 80 Mg88.08.0
Lacosamide287.77.7
Pravastatin Sodium136.76.7
Phenytoin136.36.3
Mirabegron236.16.1
Fesoterodine Fumarate65.65.6
Risperidone705.55.5
Aripiprazole635.35.3
Brivaracetam33.43.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.